Cargando…

Testosterone Replacement Therapy in Men with Untreated or Treated Prostate Cancer: Do We Have Enough Evidences?

PURPOSE: To investigate the oncologic safety of testosterone replacement therapy (TRT) in men with untreated or treated prostate cancer. MATERIALS AND METHODS: We systematically searched PubMed, Embase, and Cochrane library database from January 1941 to March 2019. RESULTS: In total, 36 articles met...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Myong, Byun, Seok-Soo, Hong, Sung Kyu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Society for Sexual Medicine and Andrology 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8443987/ https://www.ncbi.nlm.nih.gov/pubmed/32648377 http://dx.doi.org/10.5534/wjmh.190158

Ejemplares similares

Cap-assisted endoscopy: Do we have enough evidence?
por: Frieling, Thomas
Publicado: (2018)

Handgrip strength evaluation in CKD: do we have enough evidence?
por: Leal, Viviane O., et al.
Publicado: (2020)

Do prostate-specific antigen parameters have a similar role in predicting prostate cancer regardless of serum testosterone levels in men with gray-zone prostate-specific antigen levels?
por: Oh, Jeong Hoon, et al.
Publicado: (2022)

Effect of Testosterone Replacement Therapy on Cognitive Performance and Depression in Men with Testosterone Deficiency Syndrome
por: Jung, Hyun Jin, et al.
Publicado: (2016)

Regulation of nanotechnology: Are we doing enough?
por: Webster, Thomas J
Publicado: (2007)

Informed consent: Are we doing enough?
por: Pranati,
Publicado: (2010)

Less is more, but are we doing enough?
por: Ñamendys-Silva, Silvio A.
Publicado: (2019)

Testosterone replacement and prostate cancer
por: Ramasamy, Ranjith, et al.
Publicado: (2012)

Use of Corticosteroids in the management of Idiopathic Pulmonary Haemosiderosis: Do we have enough evidence
por: Mushtaq, Ammara, et al.
Publicado: (2015)

Dual Aortic Stenosis and Transthyretin Cardiac Amyloidosis: Do We Have Enough Evidence?
por: Gupta, Praveen K.
Publicado: (2022)

Testosterone replacement therapy for older men
por: Borst, Stephen E, et al.
Publicado: (2007)

Risks of testosterone replacement therapy in men
por: Osterberg, E. Charles, et al.
Publicado: (2014)

Transdermal testosterone replacement therapy in men
por: Ullah, M Iftekhar, et al.
Publicado: (2014)

Outcomes of Prostate Biopsy in Men with Hypogonadism Prior or During Testosterone Replacement Therapy
por: Shoskes, Daniel A, et al.
Publicado: (2015)

Vancomycin therapy in critically ill patients on continuous renal replacement therapy; are we doing enough?
por: Omrani, Ali S., et al.
Publicado: (2015)

Severe hypophosphatemia in the critically ill: are we replacing enough?
por: Millwood Hargrave, J, et al.
Publicado: (2015)

Osteoporosis in Saudi Arabia: Are we doing enough?
por: Alwahhabi, Basmah K.
Publicado: (2015)

Bracing in clubfoot: do we know enough?
por: Alves, C.
Publicado: (2019)

Oral submucous fibrosis: Are we doing enough?
por: Chugh, Ankita, et al.
Publicado: (2019)

Vitamin D and Lupus: Are we doing enough?
por: Chiruvolu, Neha V., et al.
Publicado: (2021)

Reply: Dual Aortic Stenosis and Transthyretin Cardiac Amyloidosis: Do We Have Enough Evidence?
por: Singal, Aayush Kumar, et al.
Publicado: (2022)

Serum Testosterone Level, Testosterone Replacement Treatment, and Prostate Cancer
por: Atan, Ali, et al.
Publicado: (2013)

Is Testosterone Replacement Safe in Men with Cardiovascular Disease?
por: Ahmed, Talha, et al.
Publicado: (2020)

Testosterone therapy in men with testosterone deficiency: Are we beyond the point of no return?
por: Traish, Abdulmaged
Publicado: (2016)

Neoadjuvant Chemotherapy for Advanced Gallbladder Cancer: Do We have Enough Evidence? A Systematic Review
por: Naveed, Shah, et al.
Publicado: (2021)

Video laryngoscopy-guided double-lumen tube insertion: Do we have enough evidence yet?
por: Gupta, Anju, et al.
Publicado: (2022)

Cell Therapy of Severe Ischemia in People with Diabetic Foot Ulcers—Do We Have Enough Evidence?
por: Dubský, Michal, et al.
Publicado: (2023)

Hand injury prevention in India: Are we doing enough?
por: Panse, Nikhil, et al.
Publicado: (2011)

Lycopene and male infertility: do we know enough?
por: Pakrashi, Tarita, et al.
Publicado: (2014)

Diabetes Prevention and Treatment Strategies: Are we doing enough?
por: Backholer, Kathryn, et al.
Publicado: (2013)

Do We Tell Our Coronary Patients Enough?
por: Trelawny-Ross, Carol P., et al.
Publicado: (1986)

Persistence in Phytopathogenic Bacteria: Do We Know Enough?
por: Martins, Paula M. M., et al.
Publicado: (2018)

The burden of type 2 diabetes: are we doing enough?
por: Zimmet, P.
Publicado: (2003)

Cancer prevention programmes in Mexico: are we doing enough?
por: Padilla-Raygoza, Nicolás, et al.
Publicado: (2020)

Stress and depression among students: Are we doing enough?
por: Tariq, Sundus, et al.
Publicado: (2022)

Recent progress in sepsis epidemiology – have we learned enough?
por: Gerlach, Herwig, et al.
Publicado: (2003)

Pseudopolyps in inflammatory bowel diseases: Have we learned enough?
por: Politis, Dimitrios S, et al.
Publicado: (2017)

Testosterone Replacement Therapy and Prostate Cancer Incidence
por: Eisenberg, Michael Louis
Publicado: (2015)

Testosterone replacement therapy and the risk of prostate cancer
por: Warburton, Daniel, et al.
Publicado: (2015)

Testosterone replacement therapy and hospitalization rates in men with COPD
por: Baillargeon, Jacques, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_khgf8h3uegk5ul15985f948jcs